id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-297365-11es4w0u	Peng, Hui	Coronavirus Disease 2019 in Children: Characteristics, Antimicrobial Treatment, and Outcomes	2020-05-07		.txt	text/plain	1697	87	52	Young children are more dependent on their family members and infants are not suitable for wearing masks, which may explain why children younger than 2 years are the most vulnerable group to COVID-19. On February 19, arbidol was included in A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Pediatric Branch of Hubei Medical Association; Pediatric Branch of Wuhan Medical Association Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response Clinical Characteristics of Children with Coronavirus Disease COVID-19 epidemic: Disease characteristics in children Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study Epidemiology of COVID-19 Among Children in China COVID-19 in Children: Initial Characterization of the Pediatric Disease Treatment of SARS with human interferons Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study Clinical Features of 69 Cases with Coronavirus Disease Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19	cache/cord-297365-11es4w0u.txt	txt/cord-297365-11es4w0u.txt
